[{"Assets_0_Q3_USD":"10942900000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q3_USD":"0.19","CommonStockDividendsPerShareDeclared_3_Q3_USD":"0.57","CommonStockSharesConverted_0_Q3_shares":"135900000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.49","EarningsPerShareBasic_3_Q3_USD":"0.36","EarningsPerShareDiluted_1_Q3_USD":"-0.49","EarningsPerShareDiluted_3_Q3_USD":"0.36","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","MinorityInterest_0_Q3_USD":"200000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"398700000.0","NetIncomeLoss_1_Q3_USD":"-67500000.0","NetIncomeLoss_3_Q3_USD":"49600000.0","OfficialName":"Perrigo Company plc Ordinary Shares","RevenuesConverted_1_Q3_USD":"1133100000.0","RevenuesConverted_3_Q3_USD":"3536500000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":"5660000000.0","StockholdersEquity_0_Q3_USD":"5659800000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"137400000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"139000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"137400000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"138500000.0","filed":"20181108","footnote":null,"form":"10-Q","fp":"Q3","fy":"2018.0","name":"PERRIGO CO PLC","period":"20180930","qtrs":"0","uom":"USD"}]